Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial


Por: Taxonera, C, Lopez-Sanroman, A, Vera-Mendoza, I, Domenech, E, Ruiz, VV, Marin-Jimenez, I, Guardiola, J, Castro, L, Esteve, M, Iglesias, E, Ceballos, D, Martinez-Montiel, P, Gisbert, JP, Minguez, M, Echarri, A, Calvet, X, Barrio, J, Hinojosa, J, Martin-Arranz, MD, Marquez-Mosquera, L, Bermejo, F, Rimola, J, Alba, C, Pons, V and Nos, P

Publicada: 1 abr 2019 Ahead of Print: 14 ene 2019
Resumen:
Background: In APPRECIA trial, Crohn's disease (CD) patients undergoing intestinal resection were randomized to postoperative adalimumab (ADA) or azathioprine (AZA). Aims: To evaluate health-related quality of life (HRQoL) in APPRECIA trial. Methods: HRQoL was evaluated using disease-specific shortened Spanish version of the IBDQ (SIBDQ-9) and generic European Quality of Life-5 Dimensions (EQ-5D) questionnaires, completed at baseline and at weeks 24 and 52. Results: Sixty-one patients (37 ADA and 24 AZA) had evaluable data for HRQoL. Patients treated with ADA or AZA had significant improvement from baseline to weeks 24 and 52 in SIBDQ-9 and EQ-5D (p < 0.001 and p = 0.006 for all comparisons, respectively). There were no differences between treatment arms in mean change in SIBDQ-9 and EQ-5D at weeks 24 and 52 vs baseline. Only patients without endoscopic recurrence had significant improvement in SIBDQ-9 (p < 0.001) and EQ-5D (p < 0.001) at week 52. At week 52, there was a high to moderate negative correlation between CDAI score with SIBDQ-9 score( Pearson's r: -0.768) and with EQ-5D index (r: -0.644). Conclusion: HRQoL improved after intestinal resection in CD, irrespective of the postoperative therapyused (ADA or AZA). Outcomes in HRQoL were associated with prevention of endoscopic recurrence, sinceimprovements in HRQoL were only significant in patients with endoscopic remission at 1 year. (c) 2019 Editrice Gastroenterologica Italiana S. r. l. Published by Elsevier Ltd. All rights reserved.

Filiaciones:
Taxonera, C:
 San Carlos Clin Hosp, San Carlos Hlth Res Inst IdISSC, IBD Unit, Madrid, Spain

Lopez-Sanroman, A:
 Ramon Y Cajal Univ Hosp, Gastroenterol Hepatol Unit, Madrid, Spain

Vera-Mendoza, I:
 Puerta de Hierro Univ Hosp, Gastroenterol Hepatol Unit, Majadahonda, Spain

:
 Germans Trias & Pujol Hosp, Gastroenterol Hepatol Unit, Badalona, Spain

 Carlos III Hlth Inst, Ctr Biomed Res Liver & Digest Dis Network CIBEReh, Madrid, Spain

Ruiz, VV:
 Puerto Real Univ Hosp, Gen Surg Unit, Puerto Real, Spain

Marin-Jimenez, I:
 Gregorio Marannon Univ Hosp, Gregorio Marannon Hlth Res Inst IiSGM, Digest Dis Unit, Madrid, Spain

Guardiola, J:
 Univ Hosp Bellvitge IDIBELL, Gastroenterol Hepatol Unit, Barcelona, Spain

Castro, L:
 Virgen de Macarena Univ Hosp, Digest Dis Unit, Seville, Spain

Esteve, M:
 Carlos III Hlth Inst, Ctr Biomed Res Liver & Digest Dis Network CIBEReh, Madrid, Spain

 Mutua Terrassa Univ Hosp, Gastroenterol Hepatol Unit, Terrassa, Spain

Iglesias, E:
 Reina Sofia Hosp, Digest Dis Unit, Cordoba, Spain

Ceballos, D:
 Univ Hosp Gran Canaria Doctor Negrin, Gastroenterol Hepatol Unit, Las Palmas Gran Canaria, Spain

Martinez-Montiel, P:
 Univ Hosp October 12, Digest Dis Unit, Madrid, Spain

Gisbert, JP:
 Carlos III Hlth Inst, Ctr Biomed Res Liver & Digest Dis Network CIBEReh, Madrid, Spain

 Univ Hosp La Princesa, Inst Invest Sanitaria La Princesa IIS IP, Digest Dis Unit, Madrid, Spain

Minguez, M:
 Univ Valencia, Clin Hosp Valencia, Digest Dis Unit, Valencia, Spain

Echarri, A:
 Arquitecto Marcide Hosp, Digest Dis Unit, Ferrol, Spain

Calvet, X:
 Carlos III Hlth Inst, Ctr Biomed Res Liver & Digest Dis Network CIBEReh, Madrid, Spain

 Healthcare Corp Parc Tauli, Digest Dis Unit, Sabadell, Spain

Barrio, J:
 Rio Hortega Univ Hosp, Digest Dis Unit, Valladolid, Spain

Hinojosa, J:
 Hosp Manises, Digest Dis Unit, Valencia, Spain

Martin-Arranz, MD:
 La Paz Univ Hosp, Digest Dis Unit, Madrid, Spain

Marquez-Mosquera, L:
 Mar Hosp, Gastroenterol Hepatol Unit, Barcelona, Spain

Bermejo, F:
 Univ Hosp Fuenlabrada, Digest Dis Unit, Fuenlabrada, Spain

Rimola, J:
 Univ Barcelona, Clin Hosp, Radiol Unit, Barcelona, Spain

Alba, C:
 San Carlos Clin Hosp, San Carlos Hlth Res Inst IdISSC, IBD Unit, Madrid, Spain

Pons, V:
 Carlos III Hlth Inst, Ctr Biomed Res Liver & Digest Dis Network CIBEReh, Madrid, Spain

 Univ La Fe, Digest Dis Unit, Valencia, Spain

 Polytech Hosp La Fe, Digest Dis Unit, Valencia, Spain

Nos, P:
 Carlos III Hlth Inst, Ctr Biomed Res Liver & Digest Dis Network CIBEReh, Madrid, Spain

 Univ La Fe, Digest Dis Unit, Valencia, Spain

 Polytech Hosp La Fe, Digest Dis Unit, Valencia, Spain
ISSN: 15908658





Digestive and Liver Disease
Editorial
W. B. Saunders Co., Ltd., STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA, Reino Unido
Tipo de documento: Article
Volumen: 51 Número: 4
Páginas: 529-535
WOS Id: 000463166800013
ID de PubMed: 30712954

MÉTRICAS